in 2022, Prime Therapeutics acquired Magellan Rx and replaced the Magellan Rx Medicare Basic Medicare Part D plan with other Medicare prescription drug plan options. Learn more.

Centene acquired Magellan Rx in January 2022 as part of its acquisition of Magellan Health, Inc. ... (including Medicare Prescription Drug Plans) ... including our annual report on Form 10-K, ...

The combination creates an opportunity to transform the industry by driving affordability and integrating whole-person care to enhance the patient, provider and customer experience. EAGAN, Minn ...

Centene has completed its $1.35 billion divestiture of Magellan Rx to Prime Therapeutics. The move adds Magellan's specialty drug management capabilities to Prime Therapeutics' suite of pharmacy ...

Designation demonstrates highest level of commitment to quality health care EAGAN, Minn., Aug. 28, 2023 /PRNewswire/ -- Prime Therapeutics LLC (Prime)/Magellan Rx (MRx) is proud to announce that ...

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies EAGAN, Minn., Aug. 24, 2023 /PRNewswire/ -- Magellan Rx ...

The combination creates an opportunity to transform the industry by driving affordability and integrating whole-person care to enhance the patient, provider and customer experience. EAGAN, Minn ...

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies EAGAN, Minn., Aug. 24, 2023 /PRNewswire/ -- Magellan Rx ...

The combination creates an opportunity to transform the industry by driving affordability and integrating whole-person care to enhance the patient, provider and customer experience. EAGAN, Minn ...